Skip to Content

Danaher Corp DHR

Morningstar Rating
$245.80 −4.61 (1.84%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

DHR is trading at a 1% discount.
Price
$253.11
Fair Value
$961.00
Uncertainty
Medium
1-Star Price
$948.93
5-Star Price
$727.80
Economic Moat
Cdtxcy
Capital Allocation
Tfrzlbspc

Bulls Say, Bears Say

Bulls

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for Danaher's long-term prospects.

Bears

Danaher continues to hunt for acquisitions in the life sciences and diagnostics markets, which could constrain ROICs including goodwill if it makes acquisitions at unattractive prices and is not able to integrate them as successfully as in the past.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DHR is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$250.41
Day Range
$245.28250.64
52-Week Range
$182.09259.00
Bid/Ask
$223.00 / $248.21
Market Cap
$182.06 Bil
Volume/Avg
169 / 2.6 Mil

Key Statistics

Price/Earnings (Normalized)
30.42
Price/Sales
8.14
Dividend Yield (Trailing)
0.43%
Dividend Yield (Forward)
0.44%
Total Yield
0.43%

Company Profile

In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Core
Total Number of Employees
63,000

Competitors

Valuation

Metric
DHR
MRK
RHHBY
Price/Earnings (Normalized)
30.4219.5811.02
Price/Book Value
3.412.455.49
Price/Sales
8.143.112.87
Price/Cash Flow
27.7214.5310.56
Price/Earnings
DHR
MRK
RHHBY

Financial Strength

Metric
DHR
MRK
RHHBY
Quick Ratio
1.340.790.99
Current Ratio
1.851.421.35
Interest Coverage
15.8511.3214.93
Quick Ratio
DHR
MRK
RHHBY

Profitability

Metric
DHR
MRK
RHHBY
Return on Assets (Normalized)
5.15%7.55%17.03%
Return on Equity (Normalized)
8.40%13.81%53.42%
Return on Invested Capital (Normalized)
6.02%10.19%26.30%
Return on Assets
DHR
MRK
RHHBY
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncCnvxmmdsNnxgz$209.3 Bil
IQV
IQVIA Holdings IncXqbkxyzKjnlshl$43.4 Bil
IDXX
IDEXX Laboratories IncMzhsjfcgxGprmdwv$41.0 Bil
A
Agilent Technologies IncXzrhdmlqkHjwf$40.3 Bil
MTD
Mettler-Toledo International IncBsqcqhknxbKkvkrp$26.4 Bil
ICLR
Icon PLCLsrbzvsdCftsnr$24.8 Bil
ILMN
Illumina IncCbmzxdpylQqwwrqg$19.3 Bil
WAT
Waters CorpPnvpwvthjQmmz$18.3 Bil
LH
Laboratory Corp of America HoldingsZvbjghhdFpbpvm$17.5 Bil

Sponsor Center